Expression profiling of Th17 cell activators revealed elevation of STAT-3 in progressing sarcoidosis

R. Fillerova, E. Kriegova, T. Tomankova, F. Mrazek, M. Zurkova, V. Kolek, M. Petrek (Olomouc, Czech Republic)

Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Session: Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Session type: Poster Discussion
Number: 4762
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Abstract

Sarcoidosis is a Th1/Th17 multisystem inflammatory disorder of unknown aetiology. Although Th17 cells have been implicated in sarcoidosis and its progression, there is limited information about the molecules involved in the Th17 immune response in sarcoidosis and its phenotypes.
We, therefore, investigated, mRNA expression of Th17 pathway activators (IL-6, IL-21, IL-23, TGFbeta, RORC, STAT-3) together with the cytokines produced by Th17 cells (IL-17A, IL-17F, IL-22) by quantitative RT-PCR in bronchoalveolar (BAL) cells from 77 sarcoidosis patients (S) and 20 control subjects (C); subanalysis was performed in sarcoid phenotypes.
Of studied Th17 activators, IL-6 (mean S/C; 0.37/0.04, p=0.0001), IL-21 (0.002/0.001, p=0.001), IL-23 (0.06/0.02, p=0.001), TGFbeta (0.86/0.51, p=0.02) and RORC (0.06/0.02, p=0.0002) were up-regulated in sarcoidosis vs. controls. Expression of Th17 cytokines did not differ between sarcoidosis and controls (p>0.05). The expression profiling in remitting (n=27) and progressing (n=40) sarcoidosis, as assessed by the disease outcome after 2 years, revealed elevation of STAT-3 in progressing sarcoidosis (p=0.01).
In conclusion, increased expression of Th17 activators (IL-6, IL-21, IL-23, TGFbeta, RORC) was observed in sarcoid BAL cells irrespective of clinical phenotype. Enhanced expression of STAT-3, an essential regulator of Th17 cells, was detected in patients with progressing sarcoidosis. Further studies on the role of STAT-3 and Th17 cells in the progression towards the fibrosis in sarcoidosis are needed.
Grant support: IGA MZ CR NS/11117, IGA MZ CR NS/10267, PU LF_2010_008.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Fillerova, E. Kriegova, T. Tomankova, F. Mrazek, M. Zurkova, V. Kolek, M. Petrek (Olomouc, Czech Republic). Expression profiling of Th17 cell activators revealed elevation of STAT-3 in progressing sarcoidosis. Eur Respir J 2011; 38: Suppl. 55, 4762

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015



ETS-1 mRNA and its association with T-BET and Th1 cytokine expression in active pulmonary sarcoidosis.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018

c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

Induced sputum differential gene expression implicates increased p38 signalling activity in severe asthma
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011


Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytes
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018


TGFβ induced myofibroblast differentiation is independent of p38 activation, but requires TGFβR1 kinase activity and correlates with TGFβ-mediated SMAD signaling and TGFβ-responsive gene expression patterns in human lung fibroblasts
Source: Eur Respir J 2004; 24: Suppl. 48, 718s
Year: 2004

Role of dexamethasone and MAPkinases ERK and p38MAPK on T-bet expression and IFNγ release in peripheral blood lymphocytes from atopic asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 229s
Year: 2006

Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe COPD
Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Year: 2010



Budesonide induces cell apoptosis, increases foxp3 expression, and reduces icos expression in T cell subpopulations of asthmatics
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009

Evaluation of mRNA expression profiling of NF-?B mediated signaling in COPD patients.
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020

A T cell-specific inhibitor of NF-kappaB and AP-1 suppresses lung fibrosis in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 101s
Year: 2004

Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016

Increased expression of lymphocyte transcription factor T-bet in COPD
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011


Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008


Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012



Chemokine mRNA expression profiling in pulmonary sarcoidosis
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008

Bile acid receptor accelerates to the lung cancer process induced by lung fibroblast-tumor cells interaction, with high activation of phosphorylated STAT3 and alteration of cytokine secretion
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Functional expression of TLR9 on BAL clls from sarcoidosis patients
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008